Ocular Therapeutix, Inc. (NASDAQ:OCUL) Stock Position Lifted by Rhumbline Advisers
Rhumbline Advisers increased its holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 2.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 213,601 shares of the biopharmaceutical company’s stock after buying an additional 5,682 shares during the period. Rhumbline Advisers’ holdings in Ocular Therapeutix were worth $1,824,000 as of its most recent […]
Rhumbline Advisers increased its holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 2.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 213,601 shares of the biopharmaceutical company’s stock after buying an additional 5,682 shares during the period. Rhumbline Advisers’ holdings in Ocular Therapeutix were worth $1,824,000 as of its most recent […]
